Instead, the companies said they planned to test a modified version of their vaccine in a smaller trial beginning in February. Rather than compare their candidate with a placebo, they said, it could be tested against a vaccine expected to be authorized by regulators for emergency use soon.from Healthcare/Biotech-Industry-Economic Times https://ift.tt/37QPynv
via IFTTT
0 comments:
Post a Comment